gene expression and function. Interestingly, not all the "classical" receptors are intranuclear and can be associated at the membrane. As described in this review, extranuclear ERs and PRs at the membrane or in the cytoplasm can interact with G proteins and signaling kinases, and other G protein coupled receptors, to mediate rapid eff ects of the hormones. The rapid actions involving cytoplasmic kinase signaling and/or extranuclear steroid receptors can result in both transcription-independent and transcriptiondependent actions. In addition, to their cognate ligands, intranuclear steroid receptors (PRs) can also be activated in a "ligand-independent" manner by neurotransmitters (dopamine; DA). In this review, the distinct classical and nonclassical cellular and molecular mechanisms of steroid hormone action will be discussed with specifi c reference to E2 and P eff ects in central and sympathetic nervous systems ( • ▶ Fig. 1 ).
Introduction

▼
Steroid hormones, estradiol (E 2 ) and progesterone (P), regulate important physiological processes including development, diff erentiation, metabolism, reproduction, learning, and memory in various species. The biological eff ects of E 2 and P are primarily mediated by binding to their classical intranuclear receptors, estrogen (ERs) and progestin receptors (PRs) that act as ligandinducible transcription factors and interact with steroid receptor coregulators to modulate target Authors S. K. Mani 1 ductive behavior. As in other steroid-sensitive tissues, the regulatory action of E 2 on behavior is believed to involve the activation of ERs, altering the expression of a number of genes, including PR gene. Progestins, including P, exert their physiological eff ects primarily by binding to E 2 -induced, intracellular PRs, which function as transcriptional factors, regulating the expression of genes and genomic neural networks to initiate and/or sustain physiological response [ 1 , 2 ] . PRs undergo signifi cant conformational change upon binding by P, leading to their nuclear translocation, dimerization and DNA binding [ 3 ] . When bound to DNA, PRs interact with basal transcriptional machinery, assisted by coactivator molecules to initiate chromatin remodeling [ 4 -6 ] . Phosphorylation of the coactivators also plays a crucial role in the activation of steroid receptors [ 7 , 8 ] . The role of coactivators is discussed below. Spatial, temporal, and functional correlations indicate that E 2 -induced PRs function as transcriptional mediators and regulate transcription of target genes to aff ect reproductive behavior [ 2 ] . The time course of activation and termination of reproductive behavior has also been shown to parallel E 2 -induced increase and decline in PRs in the hypothalamus and the preoptic areas of the brain. A wide body of literature has identifi ed diff erent neuroanatomical sites in the regulation of female sexual behavior by steroid hormones [ 9 ] . Studies using PR antagonists, protein and RNA synthesis inhibitors, antisense to oligonucleotides to PRm-RNA and PR mutant mice indicate a requirement for classical genomic mode of activation involving intracellular PRs in P-mediated facilitation of reproductive behavior [ 10 -15 ] . Studies have also demonstrated that PRs can be activated by factors other than their cognate ligand, P (ligand-independent activation). Second messenger molecules, including 3′,5′-cyclic adenosine monophosphate (cAMP), 3′,5′-cyclic guanosine monophosphate (cGMP), nitric oxide (NO), and neurotransmitter (dopamine, DA) can substitute for P in the facilitation of reproductive behavior [ 16 , 17 ] . Using PR antagonists, antisense oligonucleotides and null mutants for PRs, the critical requirement of classical PRs as transcriptional mediators in the cross talk between P and DA-initiated pathways in the facilitation of female sexual receptive behavior has been demonstrated [ 18 , 19 ] . In addition, DA-initiated second messenger signaling cascade was demonstrated to involve the activation of protein kinase A (PKA) and neuronal phosphoprotein, dopamine and cAMP regulated phosphoprotein-32 (DARPP-32) [ 20 ] . This signaling mechanism could potentially lead to the alterations in the phosphorylation dynamics and activation of PRs and/or its coregulators as discussed below. While genomic eff ects characterized by a delayed onset have traditionally been assumed to be the primary pathway for P action in the brain, recent studies suggest the involvement of "nonclassical" mechanisms of progesterone action. These nonclassical short-latency eff ects of progesterone widely aff ect cell functioning, through modulation of putative cell surface receptors, ion channels and mechanisms coupled to cytoplasmic second messenger signaling cascades, independent of gene transcription [ 21 -23 ] . In addition to P, several of its ring-A reduced metabolites have been shown to facilitate lordosis response in ovariectomized, E 2 -primed female rats via activation of MAPK pathway [ 17 ] . A number of laboratories have reported the involvement of at least 4 extranuclear kinase systems, PKA, PKC, CaMKII, and PKG in the rapid P eff ects in the VMH and POA of the female rat [ 16 , 17 , 21 , 24 -27 ] . Since the initiation of these nonclassical eff ects occurs rapidly (in seconds or minutes) and is triggered at the membrane surface, the classical model of nuclear PR-mediation is inadequate to account for these eff ects. Recent evidence suggests the involvement of 2 types of novel membrane proteins unrelated to classical PRs, progesterone membrane receptor component 1 (PGMRC1) and progesterone membrane receptors (mPRs), in P signaling in several reproductive tissues and in the brain [ 28 , 29 ] . Inhibition of MAPK signaling pathway results in reduction of P, dibutyryl-cAMP (db-cAMP)-, prostaglandin E 2 (PGE 2 )-, or GnRH-facilitated female reproductive behavior in rats [ 17 ] . These studies suggest that E 2 and P actions in the brain could involve rapid activation of multiple signal transduction pathways that converge with classical genomic pathways. 
In the classic genomic mechanism of action discussed above, nuclear receptor coregulators enhance (coactivators) or repress (corepressors) the steroid receptor transcriptional activity. Over 300 coactivators have been identifi ed, many of which have been shown to function in physiology, behavior and human disease [ 30 ] . This review will focus on the role of the steroid receptor coactivator family in metabolism and brain and behavior. The steroid receptor coactivator (SRC) family of p160 proteins consists of SRC-1 (NcoA-1), SRC-2 (GRIP1/TIF2/NCoA-2), and SRC-3 (AIB1/TRAM-1/ACTR/RAC3/pCIP). This SRC family of coactivators physically interacts with steroid receptors, including receptors for androgens (AR), estrogens (ER), progestins (PR), and glucocorticoids (GR), in a ligand-dependent manner [ 31 ] . The C-terminus of the SRCs contains 2 activation domains (AD-1 and AD-2), while the N-terminus contains a third activation domain (AD-3) and a bHLH-PAS motif (basic helix loop helix-Per Arnt Sims), which is the most conserved domain within this family of proteins. The activation domains interact with secondary coactivators known as co-coactivators. These co-coactivators act as bridging molecules between the receptor and the general transcription machinery and modify chromatin within the promoter and enhancer regions by histone acetylation and methylation [ 31 ] .
The p160 SRC Family in Metabolism ▼ All 3 members of the p160 family of coactivators are involved in metabolic homeostasis. SRC-1 is critical in maintaining energy balance by regulating both energy intake and expenditure [ 32 ] .
In support, SRC-1 knockout mice have decreased energy expenditure and a reduced thermogenic capacity and thus, are prone to obesity. One proposed mechanism of action for SRC-1 in metabolism is through its interactions with PPARγ coactivator-1α (PGC-1α), an important regulator of mitochondrial biogenesis and oxidative phosphorylation [ 32 ] . In contrast to SRC-1, SRC-2 knockout mice are leaner than wild type mice and have an increase in adaptive thermogenesis [ 33 ] . It has been suggested that the absence of SRC-2 results in enhanced interaction between SRC-1 and PGC-1α, which increases thermogenic activity. Thus, it has been proposed that the ratio of SRC-1 and SRC-2 plays a role in maintaining the balance of energy expenditure and adipogenesis through controlling PGC-1α activity [ 33 ] . SRC-3 knockouts have lower body fat content compared with wild-type mice [ 32 ] . SRC-3 mediates the transcriptional activity of PPARγ2, which is important for adipocyte diff erentiation [ 33 ] .
In support, adipocyte diff erentiation and adipogenesis are impaired in mouse embryonic fi broblasts from cells isolated from SRC-3 knockout mice or from 3T3-L1 adipocyte cells with decreased levels of SRC-3 [ 33 ] . Taken together, these studies suggest that the 3 members of the p160 SRC family play an important role in energy homeostasis.
The p160 SRC Family in Brain and Behavior
▼
A variety of recent studies indicate that 2 of the p160 SRC family members, SRC-1 and SRC-2, are important for hormone action in brain and the regulation of behavior [ 34 ] . SRC-1 and SRC-2 are expressed at high levels in the hypothalamus, cortex and hippocampus of rodents [ 34 -43 ] and birds [ 44 -47 ] . Interestingly, in contrast with the other members of the SRC family, SRC-3 is expressed sparsely in the hypothalamus [ 48 ] . In order for SRC-1 and SRC-2 to function with steroid receptors in brain, both the coactivator and receptor must be expressed in the same cells. In support, SRC-1 and SRC-2 are expressed in the majority of estradiol-induced PR cells in regions involved in metabolism and behavior, including the ventromedial hypothalamus (VMH), medial preoptic area and arcuate nucleus in rodents [ 35 , 49 ] . A variety of studies reveal that steroids infl uence the expression of these coactivators in brain [ 35 , 43 , 50 -52 ] . Moreover, proteinprotein interactions studies reveal that SRC-1 and SRC-2 from rodent brain physically associate with ER and PR in a receptor subtype-and brain region-specifi c manner [ 53 , 54 ] . A variety of studies using antisense to SRC-1 or SRC-2 mRNA indicate that these coactivators are important for hormone dependent brain development and behavior. SRC-1 is critical for normal development of hormone-dependent sexual diff erentiation of the brain and adult sexual behavior [ 40 ] . In the adult brain, SRC-1 and SRC-2 function in the VMH to modulate ERmediated transactivation of the behaviorally-relevant PR gene [ 48 , 55 ] . In addition, SRC-1 functions in the VMH to infl uence distinct ER-and PR-dependent aspects of female sexual behavior [ 56 ] . Interestingly, reduction of SRC-1 expression in this brain region by antisense altered PR function and reduced PR-dependent proceptivity (behavior by the female to solicit interaction by the male), but not PR-dependent receptivity [ 56 ] . These fi ndings suggest that reduction of SRC-1 by antisense disrupted the activity of PR signaling pathway(s) that infl uence proceptivity, while alternate PR signaling pathways, that regulate PR-dependent receptivity, remained intact and functional. These coactivators, and others, have also been found to be essential in hormone action in brain and behavior of birds [ 57 , 58 ] . The p160 family of nuclear receptor coactivators has a critical role in modulating steroid receptor action at the cellular level. In the future, it will be important to determine the role of these coactivators in nonclassical and membrane steroid signaling in brain discussed above and below, respectively. A better understanding of how these important coactivators function in brain is crucial to understanding the complex regulation of behavior and physiology by steroids.
Membrane Estrogen Receptors Activate Metabotropic Glutamate Receptor Signaling
▼
While we continue to appreciate the diversity of signaling regarding the actions of nuclear ERα, ERβ and their associated proteins, estrogen receptors are also traffi cked to the surface membrane, whereby they regulate various intracellular signaling pathways. Membrane-initiated estrogen action, both inside and outside of the nervous system has been described for quite some time [ 59 , 60 ] . Yet, the identity of these membrane associated receptors has for years remained controversial [ 61 ] . Several studies have suggested unique estrogen receptors acting at the membrane to initiate intracellular signaling [ 62 -64 ] , while others have reported that these G-protein coupled receptors, localized to endoplasmic reticulum, are not activated by E 2 and have no eff ect on intracellular signaling [ 65 ] . That said, in most systems, membrane-initiated steroid hormone action appears due to the activation of a subpopulation of ERα and ERβ that have been modifi ed to traffi c and act at the neuronal surface [ 66 , 67 ] . Determining how ERα and ERβ act at the membrane to aff ect intracellular signaling and how these estrogen receptors are traffi cked to the membrane is critical to understanding estrogen action in brain. Recent studies have focused on estradiol-mediated phosphorylation (i. e., activation) of the transcription factor CREB [ 68 , 69 ] . Phosphorylation of CREB is an important convergence point in cell signaling, and is involved in various forms of neuronal plasticity, including learning and memory, drug addiction and nociception [ 70 ] , processes also under the infl uence of estrogens [ 61 ] . Work across multiple laboratories has indicated that activation of surface estrogen receptors leads to CREB phosphorylation via stimulation of the MAPK/ERK signaling pathway [ 71 -73 ] . Furthermore, estrogen receptor knockout mice do not exhibit estrogen-dependent CREB phosphorylation, indicating the dependence upon ERα and ERβ [ 74 ] .
To elucidate the signaling mechanisms by which estradiol aff ects CREB phosphorylation, initial studies utilized primary cultures from rat hippocampus [ 75 ] . Estradiol stimulation of membrane ERα was found to initiate mGluR1 signaling. These actions of estradiol/ERα on mGluR1 were independent of glutamate and only occurred in cultures generated from female rats. ERα activation of mGluR1 signaling led to CREB phosphorylation via Gqmediated stimulation of phospholipase C (PLC), protein kinase C (PKC) and inositol trisphosphate (IP3). Interestingly, this was not the only membrane-initiated signaling pathway sensitive to estradiol. In these same neurons, estradiol-mediated activation of ERα or ERβ would lead to activation of mGluR2. Activation of these Gi/o G protein-coupled receptors by estradiol would lead to an attenuation of L-type calcium channel-mediated CREB phosphorylation. This was consistent, as well as provided a mechanism, regarding previous fi ndings of estradiol inhibition of L-type calcium channels [ 76 ] . While CREB phosphorylation is only one of many downstream targets of mGluR activation, it was somewhat surprising to observe estradiol regulating opposing processes within the same cell. That is, at least, if gonadal estrogens are the principal activators of ER/mGluR signaling. However, recent work has provided several clues that brain-derived estrogen (i. e., neuroestrogen) may be the critical mediator of rapid estrogen signaling [ 77 ] . Specifi cally, not only does estradiol directly aff ect the electrochemical state of the cell, but also synthesis of estradiol from aromatase localized to presynaptic boutons suggests estradiol may act as a neurotransmitter [ 78 -81 ] . A universal characteristic of neurotransmission is that the ligand release point is proximal to the location of the cognate receptor. Thus, if ER/mGluR signaling acts as similar to a traditional neurotransmitter system, these signaling proteins must also be spatially restricted. In fact, caveolin-1 expression was found to be essential for the functional coupling of ERα with mGluR1a, whereas, caveolin-3 is necessary for ERα and ERβ activation of mGluR2 [ 68 ] . Hence, the spatial segregation of diff erent ER/mGluR signaling pathways can allow for independent activation and inhibition of CREB phosphorylation. Because membrane estrogen receptor signaling is widespread both inside and outside of the nervous system, it was determined whether ERs were coupled to mGluR signaling in other brain regions. Similar to previous results in hippocampal cultures, bidirectional eff ects of estradiol on CREB phosphorylation, dependent on ER/mGluR signaling, were found in striatal neurons [ 68 ] . Moreover, opposing ER/mGluR processes related to CREB phosphorylation were similarly segregated by expression of either caveolin-1 or caveolin-3. Surprisingly, however, the mGluRs responsible for membrane estrogen receptor signaling in striatum were diff erent. In substitution of mGluR1a, ERα was functionally coupled to mGluR5 in striatal neurons, whereas ERα and ERβ were paired with mGluR3 as opposed to in hippocampus where these ERs activated mGluR2. These results are interesting as each of these 4 mGluRs is expressed in both hippocampus and striatum. These data suggest ERs may be promiscuous regarding their coupling to various G protein-coupled receptors. [ 82 ] . Substitution of the palmitoyl cysteine residue with alanine blocks both radiolabeling of ERα as well as membrane-initiated ERα responsiveness [ 82 -84 ] . In neurons, recent fi ndings indicate that palmitoylation of ERα and ERβ is essential for membrane ER localization, association with caveolin proteins, and activation mGluR signaling [ 81 ] .
Using a simplifi ed model system (i. e., cultured neurons) it has been possible to identify this potential mechanism of estrogen action in brain. Work from a number of labs has expanded the importance of these studies to the whole animal, to additional brain regions, and correspondingly, to additional behaviors. The fi rst report demonstrating the importance of ER/mGluR signaling related to membrane estrogen action on the regulation of rat lordosis [ 85 ] . Specifi cally, within the arcuate nucleus, ERα activation of mGluR1 signaling is essential for full sexual receptivity. In a separate study, regulation of the estrous cycle by membrane ERs is dependent on ERα activation of mGluR1 in hypothalamic astrocytes [ 86 ] . Examining dorsal root ganglion neurons in a model of nociception, estrogen receptor activation of mGluR2/3 attenuates ATP-induced increases in intracellular calcium via inhibition of L-type calcium channels [ 87 ] . Additionally, estrogen-induced masculinization of the medial preoptic area is dependent upon mGluR [ 88 ] . ER/mGluR signaling has also been demonstrated to aff ect spinogenesis [ 89 ] , and recent fi ndings indicate ER/mGluR coupling is responsible for estrogen-induced release of endocannabinoids in hippocampal neurons [ 90 ] and the potentiation of dopamine release in the female striatum following the administration of a psychostimulant [ 91 ] . Over the next several years, it is likely that other membrane actions of estradiol will also be shown dependent upon activation of mGluRs. the intermediolateral column at the thoracic and lumbar levels of the spinal cord, which synapse with postganglionic neurons located in sympathetic ganglia. Axonal projections of these neurons are dependent on several guidance and survival signals provided by target organs [ 92 ] . These neurons display immunoreactivity for one or both of the ER subtypes [ 93 , 94 ] . While almost all sympathetic neurons express ERβ, only about a third of these neurons express ERα [ 95 ] . In some instances sympathetic neurons in lumbar paravertebral and prevertebral ganglia display cytoplasmic ER-immunoreactivity [ 94 , 96 ] . This cytoplasmic distribution has been attributed to the presence of ERα isoforms lacking nuclear localization signals and thus unable to respond to estrogens [ 97 ] . The membrane ER, GPR30, may also mediate signaling. Immunohistochemical and in situ hybridization studies reveal expression of GPR30 in some regions of brain, spinal cord and peripheral tissues [ 98 ] . However, it is not known if GPR30 are expressed or function in postganglionic sympathetic neurons. Sympathetic fi bers that innervate the ovary originate mainly from the complex celiac-mesenteric ganglia. Ovarian innervation is associated with growing follicles, interstitial tissue and ovarian vasculature [ 99 ] . Two of the major neurotransmitters contained in the ovarian nerves, norepinephrine (NE) and vasoactive intestinal polypeptide (VIP), are considered modulators of steroid production [ 100 ] . Several studies show the relevance of neural sympathetic infl uence on follicular assembly, acquisition of responsiveness to gonadotropins and regulation of ovarian steroidogenesis [ 101 , 102 ] . Estradiol produced by growing ovarian follicles has signifi cant paracrine and autocrine eff ects that can infl uence gonadal physiology. Estrogen action is mediated by ERs in follicular structures and the stroma of the ovary. ERβ expression in granulosa cells is essential for cell diff erentiation and function [ 103 ] , while ERα expressed in thecal and interstitial cells are crucial for steroidogenesis [ 104 ] . Some eff ects of estradiol on sympathetic innervation are mediated by changes in the expression of neurotrophins, including nerve growth factor (NGF), a signaling molecule involved in survival and diff erentiation of sympathetic and sensorial neurons. In the rat ovary, neurotrophins are produced in cells of the follicular wall and are responsible for the development of ovarian sympathetic innervation [ 105 ] . The actions of these neurotrophins are mediated by 2 receptors: 1) the 75 kDa low-affi nity neurotrophin receptor (p75NGFR), which displays rapid association and dissociation with most members of the neurotrophin family and 2) a high-affi nity tyrosine kinase (TrkA) receptor, which binds NGF more specifi cally but with slow kinetics [ 106 ] . Estrogen-responsive elements have been identifi ed in many of the genes that code for neurotrophins or their receptors [ 107 ] . NGF production induced by estradiol exposure may diff er depending on the tissue being analyzed [ 108 ] . In addition, variations in estrogen levels alter neurotrophin receptor expression in sympathetic neurons, thus modulating neurotrophin responsiveness. This neurotrophin response varies with the neuronal population analyzed, the doses administered and the physiological status of animals (e. g., prepubertal, adult cyclic, or adult pregnant rat) [ 94 , 109 ] . Mounting evidence indicates that changes in estrogen signaling and adrenergic innervation can induce alterations in sympathetic tone. The most dramatic modifi cations are seen in the myometrial layer of uterus, where variations in levels of estrogens during the rodent estrous cycle and pregnancy induce changes in sympathetic nerve density, including a progressive loss of sympathetic activity at late gestation [ 110 ] . In the ovary, estradiol treatment induces an augmented synthesis of NGF associated with an increase in norepinephrine content that can induce long-lasting eff ects on the sympathetic innervation of the ovaries. These changes alter ovarian morphology and function; induce the development and maintenance of cystic follicles, and cause anovulation and alterations in estrous cyclicity [ 111 , 112 ] . Similar changes are found in ovaries from women with polycystic ovary syndrome (PCOS), a common cause of infertility during reproductive age [ 113 ] . In animal models of PCOS, the eff ects induced by estradiol exposure can be partially reversed by surgical sympathectomy [ 111 , 114 ] . A potential contribution of the sympathetic system to PCOS has been suggested given that polycystic ovaries show an increase in the number of sympathetic fi bers [ 115 ] and ovarian wedge resection or laparoscopic laser cauterization are eff ective in increasing the ovulatory response in women with PCOS [ 116 ] . These fi ndings raise the possibility that sympathetic input may play a role in the development and maintenance of polycystic ovaries in PCOS women. In summary, estradiol can regulate several aspects of sympathetic neuronal function through a variety of mechanisms. Neuronal target tissues can be infl uenced by these estradiol-induced changes. While estrogens can have direct eff ects by acting through neuronal ERs, they can also act indirectly to elicit changes in production of survival signals in target organs that aff ect the function of subpopulations of neurons. Knowledge of the basic mechanisms of this crosstalk is essential in understanding the pathophysiological aspects involved in the development and maintenance of complex hormone-dependent disorders aff ecting human health.
Estrogens and Sympathetic Innervation in
Conclusions
▼
The research outlined in this review (e. g., mechanisms of PR activation, transcriptional coactivators, membrane/nuclear signaling, neuronal feedback to the reproductive organs) refl ects how far the fi eld of neuroendocrinology has progressed over the last several years. Clearly, steroid hormone action in the nervous system is not a simple on/off activational relay. Based upon the role these hormones play in a diversity of physiological responses, this is not surprising. Over the next several years, we can expect basic science to provide additional breakthroughs as these fi ndings are integrated into a comprehensive study of endocrine and neuroendocrine responsiveness. This work will ultimately impact the treatment of various hormonal and metabolic disorders.
